Nevertheless, the results of our study point towards a significant role of ACC1-meditated de novo FAS in colon cancer development and highlight a potential impact of ACC1 inhibition in colon cancer prevention and therapy. The gene discussed is FAS; the disease is malignant colon neoplasm.